28 The high failure rate of therapeutics showing promise in mouse disease models to translate to 29 patients is a pressing challenge in biomedical science. However, mouse models are a useful 30 tool for evaluating mechanisms of disease and prioritizing novel therapeutic agents for clinical 31 trials. Though retrospective studies have examined the fidelity of mouse models of inflammatory 32 disease to their respective human in vivo conditions, approaches for prospective translation of 33 insights from mouse models to patients remain relatively unexplored. Here, we develop a semi-34 supervised learning approach for prospective inference of disease-associated human in vivo 35 differentially expressed genes and pathways from mouse model experiments. We examined 36 36 transcriptomic case studies where comparable phenotypes were available for mouse and 37 human inflammatory diseases and assessed multiple computational approaches for inferring 38 human in vivo biology from mouse model datasets. We found that a semi-supervised artificial 39 neural network identified significantly more true human in vivo associations than interpreting 
INTRODUCTION

80
Generalization of insights from nonhuman disease model systems to the human in vivo 81 context remains a persistent challenge in biomedical science. The association of molecular 82 features with a phenotype in model systems, particularly for inflammatory pathologies, often 83 does not hold true in the corresponding human in vivo indication, due to some combination of 84 both the fidelity of the experimental system to human in vivo biology and the inherent complexity 85 of human inflammatory disorders (1-7). Though it is now possible to collect clinical samples from 86 patients and associate molecular features with clinical phenotypes in a human in vivo context, 87 there is a discrepancy between the type and quantity of phenotypes measurable in patient 88 cohorts and those phenotypes investigable by use of mouse disease models. Outside of a 89 clinical trial, novel perturbations to the disease system cannot be directly investigated in the 90 patient in vivo context, whereas mouse disease model systems can be used to study the impact 91 of innumerable perturbations to the disease system and to associate molecular features, such 92 as differentially expressed genes (DEG), with these responses. As a consequence of this 93 discrepancy, murine and other animal model systems of disease are likely to remain an 94 important part of biomedical research. Therefore, methods for improving the generalizability of 95 mouse-derived molecular signatures to the human in vivo disease context are needed to 96 facilitate more impactful translational research.
97
The utility of mouse models for studying inflammatory pathologies in particular was recently 98 assessed by a pair of studies examining the correspondence between gene expression in 99 murine models of inflammatory pathologies and human contexts (1, 2). The human and mouse 100 microarray cohorts assembled by the two studies had the rare property that mouse molecular 101 and phenotype data were well matched to human in vivo molecular and phenotype data. This
102
property enabled systematic examination of the similarities and discrepancies between mice 103 and humans. These studies analyzed the same cohorts of mouse and human studies and came
104
to conflicting conclusions about the relevance of mouse models for inflammatory disease research, with Seok et al. concluding that mouse models poorly mimic human pathologies,
106
whereas Takao et al. concluded that mouse models usefully mimic human pathologies (1, 2).
107
The key methodological difference between the two studies was that while Seok et al. examined 108 genes changed in either mouse or human contexts, Takao 
117
The aim of our study here is to address the challenge of prospective inference of human 118 biology from a model system study by developing a machine learning approach for inferring 119 human biological associations as if the model system study had been conducted in a human 120 cohort. Within this framework, a machine learning approach is judged successful if it correctly 121 predicts a higher proportion of human DEGs and enriched signaling pathways than were 122 implicated by the corresponding mouse disease model prior to any computational analysis. The 123 essence of our approach is to apply a machine-learning classifier to assign synthetic 124 phenotypes derived from those in a mouse dataset to molecular datasets of disease-context 125 associated human samples. These synthetic phenotype labels of the human samples are then 126 used for differential expression and pathway enrichment analysis to derive a set of predicted 127 molecule-phenotype associations for the human samples. We were able to assess the efficacy 
141
RESULTS
142
Developing a framework for mouse-to-human genomic insight translation
143
We assembled a cohort of mouse-to-human translation case studies from the datasets 
146
(burn and trauma) and two conditions of complex, polygenic etiology difficult to mimic in mouse 147 models (endotoxemia and sepsis) ( 
181
The F-score provided a summarized score that gave an equal weighting on both the accuracy of
182
DEG and pathway predictions and how comprehensive the predictions were relative to the 183 human-predicted associations.
184
The mouse model-predicted DEGs and enriched pathways constituted the baseline
185
performance of mouse-to-human translation that our machine-learning approaches needed to 186 improve upon to be considered successful ( Figure 1A ). We implemented supervised and semi- 
214
In the supervised case, the mouse molecule-phenotype dataset was used to train a machine 215 learning classifier and the resulting classifier was applied to the human molecular dataset to 216 infer synthetic phenotype labels ( Figure 1B ). In the semi-supervised case, the mouse dataset
217
was first used to train a machine learning classifier in a supervised manner and then this
218
classifier was applied to infer synthetic phenotype labels in the human dataset ( Figure 1C ). (Table S1 ). However, both α (p = 0.000242) and the type of machine learning method (p = 0.00189) significantly impacted the F-score metric (Table S2 
256
The overall performance of mouse-derived DEGs for prospectively predicting human DEGs was (Table S3) . We then performed WMW tests comparing the DEG F-scores 267 between all pairs of machine learning approaches and confirmed that the ssANN performed
268
significantly better than all other machine learning approaches (Table S4) . Finally, we 269 examined the average performance of the ssANN specifically across all case studies for each 270 setting of the regularization parameter α (Table S5 ). An α value of 1.0 corresponding to Lasso Table S6 ). In most cases, the mouse model pathway F-score is 288 higher than the DEG F-score indicating that the mouse models considered here are more 
308
In comparison, in 7 of these 14 CLP mouse model cases, the ssANN was able to correctly and MAPK1 signaling (Table S7 ). This pathway signature of human sepsis appears to be highly 346 reproducible in multiple mouse sepsis models, rendering it a stable signature for assessing 347 therapeutic interventions and benchmarking mouse sepsis models against human data. 
363
suggests that a heterogeneous mouse cohort contains latent features that the ssANN is able to 364 detect and incorporate into its predictions of human in vivo pathways.
365
We then compared the combined pathway predictions of all mouse sepsis models to the 
388
In this study we demonstrate that prospective translation of biological insights from 389 mouse models to human inflammatory disease contexts was best accomplished by a semi- 
414
sepsis that all mouse models of sepsis lacked (Table S8) . By comparing the predicted enriched 
431
when the human cohort being predicted was itself heterogeneous (Figure 3b ).
432
The principles of semi-supervised learning approaches share many features with those 
446
The ideal case for characterizing the biology of human disorders would be the availability 
482
Despite advances in the fidelity of model system biology to human contexts,
483
generalizability of findings of model system experiments will continue to be a key issue in both 
496
MATERIALS AND METHODS
497
Dataset Collection and Processing
498
The datasets used in our analysis were obtained from Gene Expression Omnibus (34)
499
and selected based on their inclusion in two papers published in the Proceedings of the National 
526
nodes rounded up to the nearest integer. ANN synapse weights were computed using scaled 527 conjugate gradient backpropagation. All models were implemented in MATLAB 2016a.
528
Prior to training the algorithms, we performed feature selection with either Lasso or elastic 
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